Every recall we track for DuPont Nutrition USA, Inc — 10 in all — plus the complaints and injury reports the public filed about them.
DuPont Nutrition USA recalls bulk containers of Avicel PH-101 NF microcrystalline cellulose due to failed impurities and degradation specifications. This affects specific batch numbers produced in the USA.
DuPont Nutrition USA recalls bulk Avicel PH-102 NF containers due to failed impurities tests. This may affect food, pharmaceuticals, and industrial products using the ingredient. No specific action is required as the remedy is not stated.
DuPont Nutrition USA recalls bulk Avicel DG containers due to conductivity issues. Affected products have specific batch numbers and were manufactured in the USA. Consumers should contact DuPont for details.
DuPont Nutrition USA recalls bulk Avicel PH-200 NF containers due to failed impurities tests. Check batch numbers for affected units. No immediate action needed for consumers.
DuPont Nutrition USA recalls Avicel PH-200 NF microcrystalline cellulose due to failed impurities tests. This ingredient is used in pharmaceuticals and may not meet safety standards.
DuPont Nutrition USA recalls Avicel PH-101 NF microcrystalline cellulose due to failed impurities tests. This chemical is used in pharmaceuticals and may pose safety risks if not properly controlled.
DuPont Nutrition USA recalls Avicel PH-102 NF microcrystalline cellulose due to failed impurities tests. This product is used in pharmaceuticals and may not meet safety standards.
DuPont Nutrition USA recalls BD-102 NF Microcrystalline Cellulose bulk containers due to failed impurities tests. This may affect drug manufacturing safety. Contact for details.
DuPont Nutrition recalls Avic: RC-591 NF bulk powder due to microbial contamination. Out-of-specification results for total aerobic microbial count (TAMC) found in some lots. Affected products were manufactured at Newark, DE facility.
DuPont Nutrition recalls bulk cellulose powder PH101 NF, PH102 NF, PH200 NF due to conductivity testing failures. These excipients may not meet quality standards for pharmaceutical use.
